These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14541)

  • 1. [Multidimensional pharmacopsychiatry in gerontopsychiatry: studies on the therapy with tricyclic antidepressant drugs (author's transl)].
    Bergener M; Hesse C; Hummel F; Husser J; Kern U
    Aktuelle Gerontol; 1976 Jul; 6(7):357-64. PubMed ID: 14541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rater-specific interference factors in clinical trials (author's transl)].
    Busch H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):152-62. PubMed ID: 360240
    [No Abstract]   [Full Text] [Related]  

  • 3. [Taxonomy and assessment of psychological investigation methods in psychotropic drug trials (author's transl)].
    Baumann U; Seidenstücker G
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):165-75. PubMed ID: 360241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multidimensional diagnostics in pharmacopsychiatry/results of therapy with desmethyl-loxapine (author's transl)].
    Bergener M; Escher HD; Linden KJ
    Arzneimittelforschung; 1976 Feb; 26(2):290-9. PubMed ID: 820358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [ECG changes in psychiatric patients under long-term therapy with psychopharmacological drugs (author's transl)].
    Schwalb H; Eckmann F
    Arzneimittelforschung; 1978; 28(9):1500-1. PubMed ID: 582542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [General methodological problems of psychotropic drug trials (author's transl)].
    Heimann H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):119-29. PubMed ID: 360236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of self-rating scales in drug trials [proceedings].
    Kellner R; Simpson GM; Sheffield BF
    Psychopharmacol Bull; 1977 Apr; 13(2):42-3. PubMed ID: 859992
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotropic blood levels: a guide to clinical response.
    Yesavage JA
    J Clin Psychiatry; 1986 Sep; 47 Suppl():16-9. PubMed ID: 2875066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AMDP system and clinical psychopharmacology (author's transl)].
    Dick P
    Acta Psychiatr Belg; 1978; 78(4):583-90. PubMed ID: 716992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic-tricyclic antidepressant combination. Pharmacological aspects and therapeutic interest (author's transl)].
    Boulenger JP; Zarifian E
    Encephale; 1981; 7(1):5-28. PubMed ID: 6112132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory depression with combination reserpine and tricyclic antidepressant therapy.
    Amsterdam JD; Berwish N
    J Clin Psychopharmacol; 1987 Aug; 7(4):238-42. PubMed ID: 3305592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantitative determination of tricyclic antidepressant drugs by high-pressure liquid chromatography (author's transl)].
    Kuss BJ; Nathmann M
    Arzneimittelforschung; 1978; 28(8):1301. PubMed ID: 582392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thin-layer chromatographic determination of plasma levels of tricyclic psychopharmacological drugs: first results on their relationship to the clinical activity of neuroleptics (author's transl)].
    Breyer U; Petruch F; Gaertner HJ; Pflug B
    Arzneimittelforschung; 1976; 26(6):1153. PubMed ID: 989405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of therapeutic drug monitoring of amitriptyline and genotyping on efficacy and safety of depression therapy].
    Ostapowicz A; Zejmo M; Wrześniewska J; Białecka M; Górnik W; Gawrońska-Szklarz B
    Psychiatr Pol; 2000; 34(4):595-605. PubMed ID: 11059259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
    Müller MJ; Dragicevic A; Fric M; Gaertner I; Grasmäder K; Härtter S; Hermann E; Kuss HJ; Laux G; Oehl W; Rao ML; Rollmann N; Weigmann H; Weber-Labonte M; Hiemke C
    Pharmacopsychiatry; 2003 May; 36(3):98-104. PubMed ID: 12806567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-blind evaluation of psychopathology in drug research.
    Bobon DP
    Acta Psychiatr Belg; 1978; 78(4):635-45. PubMed ID: 362829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amineptine: clinical review (author's transl)].
    Kamoun A
    Encephale; 1979; 5(5 Suppl):721-35. PubMed ID: 548281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine naturalistic depression study (in Sweden)--MINDS(S): clinical efficacy and safety.
    Wålinder J; Prochazka J; Odén A; Sjödin I; Dahl ML; Ahlner J; Bengtsson F
    Hum Psychopharmacol; 2006 Apr; 21(3):151-8. PubMed ID: 16444795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, toxicological and electroencephalographical effects of a new tricyclic antidepressant, OI-77.
    Itil TM; Cora R; Hsu W; Gig E; Saletu B
    Arzneimittelforschung; 1972 Dec; 22(12):2063-6. PubMed ID: 4679170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.